Immunogenicity of a DNA prime and recombinant adenovirus boost regime significantly varies between rhesus macaques of Chinese and Indian origins

Journal of Medical Primatology

Volumn 36, Issue 4-5, 2007, Pages 195-205

  Stahl Hennig, Christiane ^a   Suh, You Suk ^a   Park, Ki Seok ^b   Sauermann, Ulrike ^a   Kim, Kwang Soon ^b   Ahn, Soshin ^b   Franz, Monika ^a   Schulte, Reiner ^a   Stolte Leeb, Nicole ^a   Hunsmann, Gerhard ^a   Sung, Young Chul ^b  

^a GERMAN PRIMATE CENTER   (Germany)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

AIDS; Non human primates; SIV; Vaccine

Indexed keywords

DNA VACCINE; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEF PROTEIN; NEUTRALIZING ANTIBODY; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; CHINA; CONFERENCE PAPER; CONTROLLED STUDY; DATA ANALYSIS; GENETIC DIFFERENCE; GEOGRAPHIC ORIGIN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INDIA; LYMPHOCYTE PROLIFERATION; MACACA; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; STRAIN DIFFERENCE; T LYMPHOCYTE; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, VIRAL; AREA UNDER CURVE; CELL PROLIFERATION; CHINA; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; INDIA; INTERFERON TYPE II; MACACA MULATTA; NEUTRALIZATION TESTS; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; VACCINES, DNA; VACCINES, SYNTHETIC;

ADENOVIRIDAE; MACACA; MACACA MULATTA; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 34547094849     PISSN: 00472565     EISSN: 16000684     Source Type: Journal    
DOI: 10.1111/j.1600-0684.2007.00237.x     Document Type: Conference Paper

References (32)

1. Burdo TH, Marcondes MC, Lanigan CM, Penedo MC, Fox HS: Susceptibility of Chinese rhesus monkeys to SIV infection. AIDS 2005; 19: 1704-6.
2. Casimiro DR, Wang F, Schleif WA, Liang X, Zhang ZQ, Tobery TW, Davies ME, McDermott AB, O'Connor DH, Fridman A, Bagchi A, Tussey LG, Bett AJ, Finnefrock AC, Fu TM, Tang A, Wilson KA, Chen M, Perry HC, Heidecker GJ, Freed DC, Carella A, Punt KS, Sykes KJ, Huang L, Ausensi VI, Bachinsky M, Sadasivan-Nair U, Watkins DI, Emini EA, Shiver JW: Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag. J Virol 2005; 79: 15547-55.
3. Chackerian B, Haigwood NL, Overbaugh J: Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates. Virology 1995; 213: 386-94.
4. Cohen J: AIDS research. Vaccine studies stymied by shortage of animals. Science 2000; 287: 959-60.
5. Daniel MD, Letvin NL, King NW, Kannagi M, Sehgal PK, Hunt RD, Kanki PJ, Essex M, Desrosiers RC: Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 1985; 228: 1201-4.
6. Farina SF, Gao GP, Xiang ZQ, Rux JJ, Burnett RM, Alvira MR, Marsh J, Ertl HC, Wilson JM: Replication-defective vector based on a chimpanzee adenovirus. J Virol 2001; 75: 11603-13.
7. Fauci AS, Mavilio D, Pottilil S: NK cells in HIV infection: paradigm for protection or targets for ambush. Nat Rev Immunol 2005; 5: 835-43.
8. Feinberg MB, MoCre JP: AIDS vaccine models: challenging challenge viruses. Nat Med 2002; 8: 207-10.
9. Gao F, Li Y, Decker JM, Peyerl FW, Bibollet-Ruche F, Rodenburg CM, Chen Y, Shaw DR, Allen S, Musonda R, Shaw GM, Zajac AJ, Letvin N, Hahn BH, Gao F, Li Y, Decker JM: Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: In vitro expression and immune responses in DNA-vaccinated mice. AIDS Res Hum Retroviruses 2003; 19: 817-23.
10. Gauduin MC, Glickman RL, Ahmad S, Yilma T, Johnson RP: Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production. Proc Natl Acad Sci USA 1999; 96: 14031-6.
11. Ha SJ, Chang J, Song MK, Suh YS, Jin HT, Lee CH, Nam GH, Choi G, Choi KY, Lee SH, Kim WB, Sung YC: Engineering N-glycosylation mutations in IL-12 enhances sustained cytotoxic T lymphocyte responses for DNA immunization. Nat Biotechnol 2002; 20: 381-6.
12. Ha SJ, Jeon BY, Kim SC, Kim DJ, Song MK, Sung YC, Cho SN: Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis. Gene Ther 2003; 10: 1592-99.
13. Heeney JL, Dalgleish AG, Weiss RA: Origins of HIV and the evolution of resistance to AIDS. Science 2006; 313: 462-6.
14. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, Blanchard J, Irwin CE, Safrit JT, Mittler J, Weinberger L, Kostrikis LG, Zhang L, Perelson AS, Ho DD: Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 1999; 189: 991-8.
15. Knapp LA, Lehmann E, Piekarczyk MS, Urvater JA, Watkins DI: A high frequency of Mamu A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing. Tissue Antigens 1997; 50: 657-61.
16. Lee CG, Choi SY, Park SH, Park KS, Ryu SH, Sung YC: The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met as a novel adjuvant for DNA vaccine. Vaccine 2005; 23: 4703-10.
17. Lee AH, Suh YS, Sung YC: DNA inoculations with HIV-1 recombinant genomes that express cytokine genes enhance HIV-1 specific immune responses. Vaccine 1999; 17: 473-9.
18. Letvin NL, King NW: Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Acquir Immune Defic Syndr 1990; 3: 1023-40.
19. Ling B, Veazey RS, Luckay A, Penedo C, Xu K, Lifson JD, Marx PA: SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans. AIDS 2002; 16: 1489-96.
20. Lu W, Wu X, Lu Y, Guo W, Andrieu JM: Therapeutic dendritic-cell vaccine for simian AIDS. Nat Med 2003; 9: 27-32.
21. Marcondes MC, Penedo MC, Lanigan C, Hall D, Watry DD, Zandonatti M, Fox HS: Simian immunodeficiency virus-induced CD4+ T cell deficits in cytokine secretion profile are dependent on monkey origin. Viral Immunol 2006; 19: 679-89.
22. Marthas ML, Lu D, Penedo MC, Hendrickx AG, Miller CJ: Titration of an SIVmac251 stock by vaginal inoculation of Indian and Chinese origin rhesus macaques: Transmission efficiency, viral loads, and antibody responses. AIDS Res Hum Retroviruses 2001; 17: 1455-66.
23. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272: 1167-70.
24. Montefiori DC, Metch B, McElrath MJ, Self S, Weinhold KJ, Corey L: Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines. J Infect Dis 2004; 190: 1962-9.
25. Mühl T, Krawczak M, Ten Haaft P, Hunsmann G, Sauermann U: MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys. J Immunol 2002; 169: 3438-46.
26. Pal R, Venzon D, Letvin NL, Santra S, Montefiori DC, Miller NR, Tryniszewska E, Lewis MG, VanCott TC, Hirsch V, Woodward R, Gibson A, Grace M, Dobratz E, Markham PD, Hel Z, Nacsa J, Klein M, Tartaglia J, Franchini G: ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J Virol 2002; 76: 292-302.
27. Reimann KA, Parker RA, Seaman MS, Beaudry K, Beddall M, Peterson L, Williams KC, Veazey RS, Montefiori DC, Mascola JR, Nabel GJ, Letvin NL: Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses. J Virol 2005; 79: 8878-85.
28. Spring M, Stahl-Hennig C, Stolte N, Bischofberger N, Heeney J, Ten Haaft P, Tenner-Racz K, Racz P, Lorenzen D, Hunsmann G, Dittmer U: Enhanced cellular immune response and reduced CD8(+) lymphocyte apoptosis in acutely SIV-infected Rhesus macaques after short-term antiretroviral treatment. Virology 2001; 279: 221-32.
29. Suh YS, Park KS, Sauermann U, Franz M, Norley S, Wilfingseder D, Stoiber H, Fagrouch Z, Heeney J, Hunsmann G, Stahl-Hennig C, Sung YC: Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model. Vaccine 2006; 24: 1811-20.
30. Sullivan AD, Wigginton J, Kirschner D: The coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIV. Proc Natl Acad Sci USA 2001; 98: 10214-9.
31. Trichel AM, Rajakumar PA, Murphey-Corb M: Species-specific variation in SIV disease progression between Chinese and Indian subspecies of rhesus macaque. J Med Primatol 2002; 31: 171-8.
32. Vogel T, Norley S, Beer B, Kurth R: Rapid screening for Mamu-A1-positive rhesus macaques using a SIVmac Gag peptide-specific cytotoxic T-lymphocyte assay. Immunology 1995; 84: 482-7.